Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J Maalouf
Decreased Risk of Acute Gastrointestinal Toxicity When Substituting Methotrexate With Mycophenolate Mofetil in the Prevention of Graft-Versus-Host Disease in Stem Cell Transplantation Following Myeloablative Conditioning Regimens
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Mycophenolate Mofetil for the Prevention and Treatment of Graft-Versus-Host Disease Following Stem Cell Transplantation: Preliminary Findings
Bone Marrow Transplantation
Transplantation
Hematology
The Combination of Cyclosporine and Mycophenolate Mofetil Is Less Effective Than Cyclosporine and Methotrexate in the Prevention of Acute Graft-Versus Host Disease After Stem-Cell Transplantation From Unrelated Donors
American Journal of Hematology
Hematology
Comparison of Mycophenolate Mofetil (MMF) Versus Methotrexate (MTX) for Prevention of Acute Graft-Versus-Host Disease: Results of a Meta-Analysis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Cyclosporine a and Mycophenolate Mofetil vs Cyclosporine a and Methotrexate for Graft-Versus-Host Disease Prophylaxis After Stem Cell Transplantation From HLA-identical Siblings
Bone Marrow Transplantation
Transplantation
Hematology
Folic Acid Supplementation During Methotrexate Immunosuppression Is Not Associated With Early Toxicity, Risk of Acute Graft-Versus-Host Disease or Relapse Following Hematopoietic Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Role of Conditioning Regimens in Pediatric Hematopoietic Stem Cell Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Acute and Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
Revista da Associacao Medica Brasileira
Medicine
Demodocidosis Accompanying Acute Cutaneous Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
Turkish Journal of Haematology
Hematology
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
